Clinical Psychopharmacology and Neuroscience

SJR Rank #5,088H-index: 51SJR: 0.976Best quartile: Q1Open Access
Journal website: aims, scope and author guidelines
Publisher

Korean College of Neuropsychopharmacology

Country

South Korea

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Pharmacology (medical)Q1
  • Behavioral NeuroscienceQ2
  • Psychiatry and Mental HealthQ2

Areas: Medicine · Neuroscience

Most published research topics

Schizophrenia research and treatmentTryptophan and brain disordersTreatment of Major DepressionBipolar Disorder and TreatmentAttention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorElectroconvulsive Therapy StudiesAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesStress Responses and CortisolObsessive-Compulsive Spectrum Disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs060120180240

Documents per Year

20222025020406080

Detailed Information

ISSN

2093-4327, 1738-1088

SJR Best Quartile

Q1

Region

Asiatic Region

Citations per Document (2 years)

3.51

References per Document

42.76

Coverage

2005-2026

Scope

Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of Neuropsychopharmacology (KCNP), and the associate journal for Asian College of Neuropsychopharmacology (AsCNP). This journal aims to publish evidence-based, scientifically written articles related to clinical and preclinical studies in the field of psychopharmacology and neuroscience. This journal intends to foster and encourage communications between psychiatrist, neuroscientist and all related experts in Asia as well as worldwide. It is published four times a year at the last day of February, May, August, and November.

Metrics from SCImago Journal Rank 2025. View on SCImago